Literature DB >> 15461864

Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries.

R Sessa1, M Di Pietro, G Schiavoni, M Nicoletti, G Soda, S Nardoni, D Bosco, I Santino, P Cipriani, M Del Piano.   

Abstract

Chlamydia pneumoniae has recently been associated with the development of coronary heart diseases by sero-epidemiological studies and by direct detection of the organism in atherosclerotic tissues. The aim of our study was to employ a semi-nested PCR approach to investigate the presence of C. pneumoniae in both normal and atherosclerotic coronary arteries of humans obtained at autopsy. Moreover, we have evaluated the role of infection with C. pneumoniae in relation to the extent of coronary atherosclerosis. One hundred and eighty coronary artery specimens were collected at autopsy from 60 consecutive subjects (three arterial segments from each subject). Atherosclerosis in each arterial segment was graded histologically by the Stary classification. Thirty normal coronary arteries were also taken at autopsy as control. PCR results evidenced the presence of C. pneumoniae DNA in atherosclerotic coronary arteries in 19 (31.7%) of 60 subjects examined, while none of the 30 subjects with non-atherosclerotic tissues was positive (p=0.001). Moreover, of the 180 atherosclerotic specimens examined, C. pneumoniae DNA was detected in 3.4% (2/59) of mild atherosclerotic lesions, and in 14.0% (17/121) of advanced atherosclerotic lesions (p=0.05). Our results demonstrate that the presence of C. pneumoniae DNA may be associated with the severity of coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461864     DOI: 10.1177/039463200401700310

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  5 in total

1.  Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.

Authors:  E Podsiadły; J Przyłuski; A Kwiatkowski; M Kruk; M Wszoła; R Nosek; W Rowiński; W Ruzyłło; S Tylewska-Wierzbanowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

2.  Chlamydia pneumoniae is Prevalent in Symptomatic Coronary Atherosclerotic Plaque Samples Obtained From Directional Coronary Atherectomy, but its Quantity is Not Associated With Plaque Instability: An Immunohistochemical and Molecular Study.

Authors:  Tomoyuki Otani; Kensaku Nishihira; Yoshinao Azuma; Atsushi Yamashita; Yoshisato Shibata; Yujiro Asada; Kinta Hatakeyama
Journal:  Clin Pathol       Date:  2022-09-26

Review 3.  Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Authors:  Natalia Milioti; Alexandra Bermudez-Fajardo; Manuel L Penichet; Ernesto Oviedo-Orta
Journal:  Clin Dev Immunol       Date:  2008

Review 4.  Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2013-07-19       Impact factor: 5.923

Review 5.  Mannan-binding lectin in cardiovascular disease.

Authors:  Izabela Pągowska-Klimek; Maciej Cedzyński
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.